Cargando…
The Decision to Surgically Resect Recurrent Renal Cell Carcinoma: More Evidence that Careful Case Selection by Surgeons Is Associated with Better Survival
Autor principal: | Russo, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918741/ https://www.ncbi.nlm.nih.gov/pubmed/36785748 http://dx.doi.org/10.1016/j.euros.2023.01.006 |
Ejemplares similares
-
Creating equity in health research to drive more and better evidence
por: Lang, Trudie, et al.
Publicado: (2022) -
Checklist for Transurethral Resection of Bladder Tumor (TURBT): A Step Forward in the Standardization for TURBT Reporting
por: Martínez-Piñeiro, Luis
Publicado: (2022) -
Is Surgical Tracheostomy Better Than Percutaneous Tracheostomy in Coronavirus Disease 2019–Positive Patients?
por: Bassi, Massimiliano, et al.
Publicado: (2020) -
Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer?
por: Kartolo, Adi, et al.
Publicado: (2021) -
Jury selection - Photowalk 2018
por: Favero, Cedric, et al.
Publicado: (2018)